Minerals Technologies Inc. — FY2021 Form 10-K
Business context and reporting period. This annual report covers the fiscal year ended December 31, 2021; it is not a standalone fourth-quarter report. Minerals Technologies develops and sells specialty mineral, mineral-based and synthetic mineral products and related services. Its three reportable segments are Performance Materials, Specialty Minerals and Refractories. In the first quarter of 2021, Energy Services was combined into Performance Materials.
Financial performance
| Metric | FY2021 | FY2020 |
|---|---|---|
| Net sales | $1,858.3 million | $1,594.8 million |
| Production margin | $446.5 million; 24.0% | $405.4 million; 25.4% |
| Income from operations | $235.7 million; 12.7% margin | $187.9 million; 11.8% margin |
| Net income attributable to MTI | $164.4 million | $112.4 million |
| Diluted EPS | $4.86 | $3.29 |
| Cash provided by operations | $232.4 million | $240.6 million |
| Cash and short-term investments at year-end | $304.4 million | $371.8 million |
Sales increased 16.5% (about 17%); foreign exchange contributed approximately $27 million, or 2 percentage points. Cost of sales rose 18.7%, and production margin contracted 1.4 percentage points as pricing actions lagged inflation and higher energy, manufacturing, supply-chain and logistics costs. Net income growth also reflected higher operating income and lower non-operating deductions. The effective tax rate was 18.1%, versus 17.7%.
Segment results: Performance Materials sales were $976.0 million and operating income $125.0 million (12.8% margin); Specialty Minerals sales were $578.9 million and operating income $72.9 million (12.6%); Refractories sales were $303.4 million and operating income $49.3 million (16.2%). All three segments increased sales and operating income year over year. Refractories’ operating income rose 38.9%, supported by improved steel-market activity and operating performance.
Cash, debt and liquidity: Operating cash flow was $232.4 million. Capital expenditures were $86.0 million, and cash paid for acquisitions, net of cash acquired, was $194.4 million. The company reported $1,031.1 million of aggregate principal debt in MD&A, including $80.0 million drawn on its $300 million revolving facility; the balance sheet showed $937.0 million of long-term debt and $80.0 million of short-term debt. It reported more than $500 million of available liquidity, including cash and revolver availability, and was in compliance with debt covenants. The company repurchased $74.7 million of stock and paid $6.8 million in dividends during 2021.
Changes versus the prior year and notable items
- Normerica was acquired on July 26, 2021 for approximately $189 million; it contributed $48.6 million of 2021 sales. Its preliminary purchase-price allocation included $104.5 million of goodwill and $68.1 million of intangible assets. The company also acquired Specialty PCC assets for $6.9 million in November.
- Performance Materials growth reflected the Normerica acquisition and stronger consumer-oriented and metalcasting demand. Specialty Minerals benefited from higher paper-mill operating rates, ramp-up of satellite plants and demand in construction and automotive markets. Refractories recovered with improved steel-mill utilization.
- 2021 operating income included $4.0 million of acquisition-related costs and $1.1 million of restructuring and other costs. FY2020 included $10.4 million of Novinda-related litigation expense, $7.6 million of restructuring and asset write-downs, $4.0 million of ransomware remediation costs and $3.1 million of acquisition costs.
- Cash flow from operations declined by $8.2 million year over year, with higher inventory use of cash among the disclosed working-capital movements. Cash and short-term investments fell $67.4 million from year-end 2020.
Outlook, risks and contingencies
The filing provides no specific consolidated revenue, earnings or EPS guidance for 2022. Management outlined growth priorities including geographic expansion, product innovation, pet care, packaging and paper technologies, and selective acquisitions. It expected 2022 capital expenditures of $85–$95 million. Management expected paper consumption to be similar to 2021 and steel consumption similar or slightly better; it stated that COVID-19 was not expected to negatively affect 2022 results, while acknowledging uncertainty around future developments.
- Costs and supply: Inflation in energy, commodities, labor and freight, supply-chain disruption and volatile shipping costs may pressure margins; pricing recovery can lag or prove incomplete. Approximately 46% of magnesia requirements over the prior five years came from China, although alternate sources have reduced reliance.
- Market and customer exposure: Several end markets are cyclical. Structural declines in printing and writing paper, paper-mill closures, customer consolidation, and failure to renew satellite PCC contracts could affect sales or asset values.
- Debt and rates: A significant portion of borrowing was LIBOR-based, with benchmark transition risk. Debt covenants restrict certain actions; the company reported compliance at year-end.
- Other risks: COVID-19, foreign exchange and geopolitical exposure, environmental and mining regulation, operational disruptions, pension assumptions, and cybersecurity. The company disclosed a ransomware incident detected in October 2020; remediation costs were recorded in 2020, and it reported no material impact from that incident to date.
- Contingencies: The company is involved in routine litigation and silica- and asbestos-related cases. Management did not expect known claims, individually or collectively, to materially affect results, cash flows or financial condition; certain legacy claims may be covered by Pfizer indemnification.
KPMG issued unqualified opinions on the financial statements and internal control over financial reporting. Normerica was excluded from the 2021 internal-control assessment; management planned to bring it into scope for 2022.
Important facts for investors to verify
- Reconcile the MD&A aggregate principal debt figure with balance-sheet carrying amounts and confirm subsequent debt repayment, refinancing and LIBOR-transition developments.
- Track whether pricing actions and productivity gains offset inflation, freight, labor and logistics costs, and whether margins recover.
- Assess Normerica integration, acquisition accounting finalization, and the contribution and returns from the pet-care and Specialty PCC acquisitions.
- Monitor paper-mill utilization, satellite contract renewals, new plant ramp-ups and structural demand shifts in printing and writing paper.
- Review 2022 capital spending against the stated $85–$95 million range, cash conversion, liquidity and ongoing share repurchases.